SCHEMBL13338684

SCHEMBL13338684

COc1ccc(N(c2ccc(-c3ccccc3)cc2)C(C)C)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 2/20 0.49
ALDH1A1 P00352 4/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
KDM4E B2RXH2 2/20 0.46
LMNA P02545 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
CYP3A4 P08684 1/20 0.46
CA4 P22748 1/20 0.45
SLC2A1 P11166 1/20 0.44
ABL1 P00519 1/20 0.44
ABCB1 P08183 1/20 0.44
BCR P11274 1/20 0.44
LTA4H P09960 1/20 0.44
ALOX5 P09917 1/20 0.43
MITF O75030 1/20 0.43
HTT P42858 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21999768 0.96 CA4 (0.45) BACE1ALDH1A1NPC1RAB9AKDM4E
SCHEMBL13408672 0.91 CA4 (0.50) ALDH1A1NPC1RAB9AKDM4ELMNA
SCHEMBL13338375 0.87 SLC2A1 (0.55) ALDH1A1NPC1RAB9AKDM4ENPSR1
SCHEMBL11910685 0.87 PTGS2 (0.47) ALDH1A1NPC1RAB9AKDM4ELMNA
SCHEMBL19049724 0.86 CA4 (0.45) ALDH1A1NPC1RAB9AKDM4ELMNA
SCHEMBL13338819 0.85 CYP1A2 (0.49) ALDH1A1NPC1RAB9AKDM4ELMNA
SCHEMBL13338406 0.85 ALDH1A1 (0.47) ALDH1A1NPC1RAB9AKDM4ELMNA
SCHEMBL18594383 0.85 ALDH1A1 (0.47) ALDH1A1NPC1RAB9AKDM4ELMNA
SCHEMBL27374348 0.81 MAPT (0.44) ALDH1A1NPC1RAB9ALMNATDP1
SCHEMBL13338780 0.81 SLC2A1 (0.45) ALDH1A1L3MBTL1CA4SLC2A1LTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100108997-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100108997-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OR10J3, OCIAD1, OCIAD2 BACE1 2841/4885ALDH1A1 428/4885NPC1 1433/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.